1140.6000 -8.50 (-0.74%)
NSE Nov 06, 2025 15:31 PM
Volume: 1.4M
 

1140.60
-0.74%
Aurobindo Pharma Ltd - 524804 - Board Meeting Outcome for Outcome Of The Board Meeting Held …
BSE India
The Board of Directors of the Company at its meeting held today, November 5, 2025, has, inter alia, considered and approved the standalone and consolidated Unaudited Financial Results of the Company for the second quarter and half year ended September 30, 2025, pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. We enclose herewith the said Unaudited Financial Results of the Company along with the Limited Review Reports issued by the Statutory Auditors.
More from Aurobindo Pharma Ltd.
Recommended